Mei-Chuan Chen Selected Research

Interleukin-33

1/2021

Anti-IgE therapy inhibits chemotaxis, proliferation and transformation of circulating fibrocytes in patients with severe allergic asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mei-Chuan Chen Research Topics

Disease

19	Neoplasms (Cancer) 12/2021 - 01/2012
5	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 05/2014
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020 - 01/2012
4	Infections 01/2022 - 05/2013
3	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 03/2011
3	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 01/2011
2	Lung Neoplasms (Lung Cancer) 12/2021 - 08/2013
2	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 01/2016
1	Lung Injury 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	COVID-19 01/2022
1	Fibrosis (Cirrhosis) 06/2021
1	Asthma (Bronchial Asthma) 01/2021
1	Airway Remodeling 01/2021
1	Disease Progression 10/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020
1	Nephritis 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Hypercholesterolemia 01/2017
1	Hyperlipidemias (Hyperlipidemia) 01/2017
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Polyploidy 01/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016
1	Carcinoma (Carcinomatosis) 01/2016
1	Rhabdomyolysis 03/2015
1	Acute Intermittent Porphyria (Porphyria, Acute) 03/2015
1	Humeral Fractures 07/2014
1	Liver Neoplasms (Liver Cancer) 03/2014

Drug/Important Bio-Agent (IBA)

4	Histone Deacetylase InhibitorsIBA 06/2021 - 01/2011
3	Antineoplastic Agents (Antineoplastics)IBA 10/2020 - 01/2016
3	Histone Deacetylases (Histone Deacetylase)IBA 10/2019 - 01/2011
3	TubulinIBA 01/2019 - 09/2014
2	Hydroxamic Acids (Hydroxamic Acid)IBA 12/2021 - 02/2017
2	quinolineIBA 12/2021 - 10/2019
2	B7-H1 AntigenIBA 03/2020 - 10/2019
2	FlavonoidsIBA 05/2019 - 04/2017
2	artocarpin lectinIBA 05/2019 - 04/2017
2	Phosphotransferases (Kinase)IBA 01/2017 - 01/2014
2	BenzenesulfonamidesIBA 01/2017 - 08/2015
2	Pharmaceutical PreparationsIBA 01/2016 - 06/2015
2	Histone Deacetylase 6IBA 10/2015 - 05/2014
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2014 - 01/2012
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Ferritins (Ferritin)IBA 01/2022
1	Pargyline (Pargyline Hydrochloride)FDA Link 12/2021
1	Protein Isoforms (Isoforms)IBA 12/2021
1	AcidsIBA 12/2021
1	CollagenIBA 06/2021
1	Plasminogen Activator Inhibitor 1IBA 06/2021
1	Plasminogen Activators (Plasminogen Activator)IBA 06/2021
1	lipoteichoic acidIBA 06/2021
1	Doxycycline (Periostat)FDA LinkGeneric 06/2021
1	Biological ProductsIBA 01/2021
1	Interleukin-33IBA 01/2021
1	Omalizumab (Xolair)FDA Link 01/2021
1	Interleukin-13IBA 01/2021
1	Angiogenesis InhibitorsIBA 01/2021
1	anti-IgE antibodiesIBA 01/2021
1	AfatinibIBA 03/2020
1	compound 17IBA 03/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	erdafitinibIBA 01/2020
1	CateninsIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	pyrimidineIBA 01/2020
1	PF-670462IBA 01/2020
1	AmidesIBA 10/2019
1	resorcinol (resorcin)IBA 10/2019
1	benzamideIBA 01/2019
1	SS-A antibodiesIBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	ZincIBA 02/2017
1	dactolisibIBA 01/2017
1	Cyclin B1IBA 01/2017
1	dendrophenolIBA 01/2017
1	antroquinonolIBA 01/2017
1	4-acetylantroquinonol BIBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	LigandsIBA 01/2016
1	3- (1- (4- methoxybenzenesulfonyl)- 2,3- dihydro- 1H- indol- 5- yl)- N- hydroxyacrylamideIBA 01/2016
1	CaspasesIBA 01/2016
1	Cisplatin (Platino)FDA LinkGeneric 01/2016
1	Antimitotic AgentsIBA 01/2016
1	compound 21IBA 08/2015
1	diphenyl (biphenyl)IBA 08/2015
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 06/2015
1	AntimetabolitesIBA 06/2015
1	Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA 03/2015
1	7- (4- cyanophenylamino)- 1- (4- methoxybenzenesulfonyl)indolineIBA 09/2014
1	7-azaindole dimerIBA 05/2014
1	Sorafenib (BAY 43-9006)FDA Link 03/2014
1	3- (1- benzenesulfonyl- 2,3- dihydro- 1H- indol- 5- yl)- N- hydroxyacrylamideIBA 03/2014

Therapy/Procedure

9	Therapeutics 01/2022 - 03/2011
2	Fracture Fixation 01/2015 - 07/2014
1	Intravenous Infusions 01/2022
1	Bone Lengthening 01/2015
1	Bone Wires 07/2014
1	Postoperative Care 07/2014